Series A Completed
Myricx Bio Series A
£90m raised
Announced 8 Jul 2024
Investors
Led by
- Novo Holdings · Co-lead
- Abingworth · Co-lead
With
- British Patient Capital
- Cancer Research Horizons
- Eli Lilly and Company
- Brandon Capital Partners · Existing investor
- Sofinnova Partners · Existing investor
Investors as the sources name them; a linked name has a FundComb profile. An existing investor is one the source says followed on.
- Company
- Myricx Bio
- Stage
- Series A
- Amount raised
- £90m
- Company based in
- United Kingdom
Similar rounds
- Samsara Eco Series A+ Jun 2024 · A$99m · led by Temasek
- Alvys Series A Jul 2024 · A$30.4m · led by Titanium Ventures
- Qodo Series A Sep 2024 · A$59.3m · led by Square Peg Capital
- Re-Leased Series A 2024 · A$19m · led by Movac
- FUZE Technology Series A Jun 2024 · A$17.5m · led by Beverly Pacific
Sources
- 8 Jul 2024 Myricx Bio announces £90m ($114m) Series A financing brandoncapital.vc
- 8 Jul 2024 Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development brandonbiocatalyst.com